Discover open access scientific publications

Search, annotate, share and cite publications

Publications by N Kröger

SRSF2 and U2AF1 Mutations in Primary Myelofibrosis Are Associated With JAK2 and MPL but Not Calreticulin Mutation and May Independently Reoccur After Allogeneic Stem Cell Transplantation

Leukemia

English

Long-Term Outcome of Patients With Newly Diagnosed Chronic Myeloid Leukemia: A Randomized Comparison of Stem Cell Transplantation With Drug Treatment

English

Toxicity-Reduced, Myeloablative Allograft Followed by Lenalidomide Maintenance as Salvage Therapy for Refractory/Relapsed Myeloma Patients

Bone Marrow Transplantation

Transplantation

Hematology

2012

English

Similar Outcome of Calreticulin Type I and Calreticulin Type II Mutations Following RIC Allogeneic Haematopoietic Stem Cell Transplantation for Myelofibrosis

Bone Marrow Transplantation

Transplantation

Hematology

2016

English

Fear of Recurrence and Its Impact on Quality of Life in Patients With Hematological Cancers in the Course of Allogeneic Hematopoietic SCT

Bone Marrow Transplantation

Transplantation

Hematology

2014

English

Allogeneic Stem Cell Transplantation After Conditioning With Treosulfan, Etoposide and Cyclophosphamide for Patients With ALL: A Phase II-study on Behalf of the German Cooperative Transplant Study Group and ALL Study Group (GMALL)

Bone Marrow Transplantation

Transplantation

Hematology

2015

English

Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM): Introduction by the Co-Chairpersons of the COSTEM Congress

Leukemia Supplements

2012

English

Efficacy and Toxicity of Low-Dose Escalating Donor Lymphocyte Infusion Given After Reduced Intensity Conditioning Allograft for Multiple Myeloma

English

Aldehyde Dehydrogenase Activity as a Marker for the Quality of Hematopoietic Stem Cell Transplants

Bone Marrow Transplantation

Transplantation

Hematology

2005

English

Lenalidomide as Salvage Therapy After Allo-SCT for Multiple Myeloma Is Effective and Leads to an Increase of Activated NK (NKp44+) and T (HLA-DR+) Cells

Bone Marrow Transplantation

Transplantation

Hematology

2009

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by N Kröger

SRSF2 and U2AF1 Mutations in Primary Myelofibrosis Are Associated With JAK2 and MPL but Not Calreticulin Mutation and May Independently Reoccur After Allogeneic Stem Cell Transplantation

Long-Term Outcome of Patients With Newly Diagnosed Chronic Myeloid Leukemia: A Randomized Comparison of Stem Cell Transplantation With Drug Treatment

Toxicity-Reduced, Myeloablative Allograft Followed by Lenalidomide Maintenance as Salvage Therapy for Refractory/Relapsed Myeloma Patients

Similar Outcome of Calreticulin Type I and Calreticulin Type II Mutations Following RIC Allogeneic Haematopoietic Stem Cell Transplantation for Myelofibrosis

Fear of Recurrence and Its Impact on Quality of Life in Patients With Hematological Cancers in the Course of Allogeneic Hematopoietic SCT

Allogeneic Stem Cell Transplantation After Conditioning With Treosulfan, Etoposide and Cyclophosphamide for Patients With ALL: A Phase II-study on Behalf of the German Cooperative Transplant Study Group and ALL Study Group (GMALL)

Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM): Introduction by the Co-Chairpersons of the COSTEM Congress

Efficacy and Toxicity of Low-Dose Escalating Donor Lymphocyte Infusion Given After Reduced Intensity Conditioning Allograft for Multiple Myeloma

Aldehyde Dehydrogenase Activity as a Marker for the Quality of Hematopoietic Stem Cell Transplants

Lenalidomide as Salvage Therapy After Allo-SCT for Multiple Myeloma Is Effective and Leads to an Increase of Activated NK (NKp44+) and T (HLA-DR+) Cells